Experience With the Use of Baricitinib and Tocilizumab Monotherapy or Combined, in Patients With Interstitial Pneumonia Secondary to Coronavirus COVID19: A Real-World Study

Experience With the Use of Baricitinib and Tocilizumab Monotherapy

Use of Baricitinib in Treatment of COVID-19: A Systematic Review

Frontiers The Efficacy and Safety of Janus Kinase Inhibitors for

Repurposing clinically available drugs and therapies for

The signal pathways and treatment of cytokine storm in COVID-19

Triple immune modulator therapy for aberrant hyperinflammatory

Tocilizumab in patients hospitalised with COVID-19 pneumonia

Frontiers The effects of combination-therapy of tocilizumab and

Use of Baricitinib in Treatment of COVID-19: A Systematic Review

Post-COVID-19 interstitial lung disease presenting with profound

Tocilizumab treatment for COVID-19 patients: a systematic review